Tonix Pharmaceuticals Names George Lederman EVP of Strategy and Transformation

• Tonix Pharmaceuticals appointed George Lederman executive vice president of strategy and transformation, effective October 30, 2026.
• Lederman previously served as vice president of global strategy at Aliaxis and was an associate partner at McKinsey & Company.
• He will lead AI initiatives to improve efficiency and cut costs, while pursuing partnerships and licensing opportunities to share clinical development costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tonix Pharmaceuticals Holding Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611020700PRIMZONEFULLFEED9867878) on November 02, 2026, and is solely responsible for the information contained therein.